Injection, Casirivimab and Imdevimab, 2400 mg (Q0243)

Name of the Procedure:

Common names: COVID-19 Monoclonal Antibody Therapy
Technical/Medical terms: Injection, Casirivimab and Imdevimab, 2400 mg

Summary

The injection of Casirivimab and Imdevimab is a monoclonal antibody therapy used to treat COVID-19. This combination helps the immune system to block the virus from entering human cells, thereby reducing the severity of the disease.

Purpose

Medical conditions addressed:

• COVID-19 infection in patients who are at high risk of progressing to severe COVID-19, including hospitalization or death.

Goals/Expected outcomes:

• To provide an effective treatment that reduces the risk of severe COVID-19 symptoms.
• To decrease the likelihood of hospitalization and improve the recovery timeline.

Indications

Symptoms/Conditions:

• COVID-19 positive patients with mild to moderate symptoms.
• Patients having high-risk factors such as older age, obesity, chronic kidney disease, diabetes, immunosuppressive disease, or cardiovascular disease.

Patient criteria:

• Must be 12 years of age or older and weigh at least 40 kg.
• Must have a confirmed positive COVID-19 test.
• Must be within 10 days of symptom onset.

Preparation

Pre-procedure instructions:

• No specific fasting or dietary changes are needed.
• Inform the healthcare provider of all medications and supplements currently being taken.

Diagnostic tests/assessments:

• A positive COVID-19 diagnostic test (PCR or antigen test).
• Possible baseline blood work and vital signs assessment.

Procedure Description

• The combination dose of Casirivimab and Imdevimab totals 2400 mg.
• The medication is administered via intravenous (IV) infusion over a period of time, typically an hour.
• This procedure may involve monitoring vital signs during and after the infusion to detect any adverse reactions.

Tools/Equipment:

• IV infusion setup, including catheter and infusion pump.
• Casirivimab and Imdevimab pre-mixed solution.

Anesthesia/Sedation:

• Generally, no anesthesia or sedation is required.

Duration

The procedure typically takes about 1 to 1.5 hours, including preparation and post-infusion monitoring.

Setting

The procedure is typically performed in a hospital, outpatient clinic, or a specialized infusion center.

Personnel

• Registered nurses or nurse practitioners who manage the IV infusion.
• Physicians who oversee the treatment and handle any complications.
• Additional support staff for patient monitoring.

Risks and Complications

Common Risks:

• Infusion-related reactions (e.g., fever, chills, headache, dizziness).

Rare Risks:

• Severe allergic reactions such as anaphylaxis.
• Potential worsening of COVID-19 symptoms.

Management:

• Immediate medical intervention for severe reactions.
• Continuous monitoring during and after the infusion to manage any adverse effects.

Benefits

Expected benefits:

• Reduced severity of COVID-19 symptoms.
• Lowered risk of hospitalization and death related to COVID-19.
• Symptoms improvement within a few days following treatment.

Recovery

Post-procedure care:

• Observation for at least an hour post-infusion for any adverse reactions.
• Instructions for home care and when to seek medical attention.

Expected recovery time:

• Generally, patients can return to normal activities after the observation period, but must continue to follow COVID-19 isolation guidelines.

Restrictions/Follow-ups:

• Follow-up appointments as needed to monitor recovery progress.

Alternatives

Other treatment options:

• Antiviral medications like Remdesivir.
• Symptomatic treatment with supportive care.
• COVID-19 vaccination for prevention.

Pros and Cons:

• Monoclonal antibody therapy is specifically targeted and can be effective quickly but is generally more costly and logistically demanding.
• Antiviral medications and vaccines might be more accessible but may not provide immediate symptom relief for infected high-risk patients.

Patient Experience

During the procedure:

• The patient may feel minor discomfort from the IV needle insertion.
• Possible temporary reactions like chills or headache during the infusion.

After the procedure:

• Some patients may experience mild symptoms like fatigue, which usually resolve on their own.
• Pain management may include over-the-counter pain relievers, with healthcare providers ensuring patient comfort throughout the process.